202 related articles for article (PubMed ID: 9015068)
41. MR imaging of soft-tissue masses: role of gadopentetate dimeglumine.
Benedikt RA; Jelinek JS; Kransdorf MJ; Moser RP; Berrey BH
J Magn Reson Imaging; 1994; 4(3):485-90. PubMed ID: 8061453
[TBL] [Abstract][Full Text] [Related]
42. Do mammography, sonography, and MR mammography have a diagnostic benefit compared with mammography and sonography?
Müller-Schimpfle M; Stoll P; Stern W; Kurz S; Dammann F; Claussen CD
AJR Am J Roentgenol; 1997 May; 168(5):1323-9. PubMed ID: 9129436
[TBL] [Abstract][Full Text] [Related]
43. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
Pediconi F; Catalano C; Padula S; Roselli A; Dominelli V; Cagioli S; Kirchin MA; Pirovano G; Passariello R
AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
[TBL] [Abstract][Full Text] [Related]
44. Technetium-99m-sestamibi scintimammography to detect breast cancer in patients with paraffinomas or siliconomas after breast augmentation.
Peng NJ; Chang HT; Tsay DG; Liu RS
Cancer Biother Radiopharm; 2003 Aug; 18(4):573-80. PubMed ID: 14503952
[TBL] [Abstract][Full Text] [Related]
45. Comparison of 99mTc-sestamibi scintimammography and dynamic MR imaging as adjuncts to mammography in the diagnosis of breast cancer.
Boné B; Wiberg MK; Szabó BK; Szakos A; Danielsson R
Acta Radiol; 2003 Jan; 44(1):28-34. PubMed ID: 12630995
[TBL] [Abstract][Full Text] [Related]
46. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
Collarino A; de Koster EJ; Valdés Olmos RA; de Geus-Oei LF; Pereira Arias-Bouda LM
Clin Breast Cancer; 2018 Feb; 18(1):9-18. PubMed ID: 28728876
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic value of (99m)Tc-3PRGD2 scintimammography for differentiation of malignant from benign breast lesions: Comparison of visual and semi-quantitative analysis.
Chen Q; Xie Q; Zhao M; Chen B; Gao S; Zhang H; Xing H; Ma Q
Hell J Nucl Med; 2015; 18(3):193-8. PubMed ID: 26574690
[TBL] [Abstract][Full Text] [Related]
48. LAT-1 based primary breast cancer detection by [99m]Tc-labeled DTPA-bis-methionine scintimammography: first results using indigenously developed single vial kit preparation.
Sharma S; Singh B; Mishra AK; Rathod D; Hazari PP; Chuttani K; Chopra S; Singh PM; Abrar ML; Mittal BR; Singh G
Cancer Biother Radiopharm; 2014 Sep; 29(7):283-8. PubMed ID: 25203145
[TBL] [Abstract][Full Text] [Related]
49. Technetium-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses.
Lee JK; Kao CH; Sun SS
Oncol Rep; 1999; 6(3):659-63. PubMed ID: 10203611
[TBL] [Abstract][Full Text] [Related]
50. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast.
Rhodes DJ; O'Connor MK; Phillips SW; Smith RL; Collins DA
Mayo Clin Proc; 2005 Jan; 80(1):24-30. PubMed ID: 15667025
[TBL] [Abstract][Full Text] [Related]
51. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
[TBL] [Abstract][Full Text] [Related]
52. Comparative value of 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses.
Klaus AJ; Klingensmith WC; Parker SH; Stavros AT; Sutherland JD; Aldrete KD
AJR Am J Roentgenol; 2000 Jun; 174(6):1779-83. PubMed ID: 10845522
[TBL] [Abstract][Full Text] [Related]
53. Magnetization transfer contrast in gadopentetate-dimeglumine-enhanced breast magnetic resonance imaging at 0.1 Tesla.
Dean KI; Komu M; Dean PB; Kormano M
Invest Radiol; 1994 Jun; 29 Suppl 2():S302-3. PubMed ID: 7928264
[No Abstract] [Full Text] [Related]
54. Usefulness of thallium-201 SPECT scintimammography to differentiate benign from malignant breast masses in mammographically dense breasts.
Chiou JF; Lin MC; Chen DR; Jim YF; Kao CH
Cancer Invest; 2003; 21(6):863-8. PubMed ID: 14735690
[TBL] [Abstract][Full Text] [Related]
55. MR imaging of the breast with Gd-DTPA enhancement: comparison with mammography and ultrasonography.
Hachiya J; Seki T; Okada M; Nitatori T; Korenaga T; Furuya Y
Radiat Med; 1991; 9(6):232-40. PubMed ID: 1668410
[TBL] [Abstract][Full Text] [Related]
56. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
[TBL] [Abstract][Full Text] [Related]
57. Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography.
Tiling R; Kessler M; Untch M; Sommer H; Linke R; Hahn K
Eur J Radiol; 2005 Feb; 53(2):206-12. PubMed ID: 15664284
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions.
Boné B; Péntek Z; Perbeck L; Veress B
Acta Radiol; 1997 Jul; 38(4 Pt 1):489-96. PubMed ID: 9240665
[TBL] [Abstract][Full Text] [Related]
59. [Gammography using Tc 99m MIBI in patients with suspected breast cancer. Proposed diagnostic protocol].
Prats E; Abós M; Aisa F; Villavieja L; Asenjo M; García-López F; Tomás A; Sainz J; Razola P; Banzo J
Rev Esp Med Nucl; 1998; 17(2):73-81. PubMed ID: 9611276
[TBL] [Abstract][Full Text] [Related]
60. Scintimammography and single-photon emission computed tomography for postoperative image guidance for radiation treatment planning in breast cancer patients.
Piperkova E; Chavdarova L; Garanina Z; Gocheva L; Parvanova V; Tzonevska A; Dimitrova M
J BUON; 2011; 16(4):657-63. PubMed ID: 22331718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
